Related Experiment Video
Updated: Mar 25, 2026

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Mushroom Lectins as Promising Anticancer Substances.
Ram Sarup Singh1, Hemant Preet Kaur, Jagat Rakesh Kanwar
1Carbohydrate and Protein Biotechnology Laboratory, Department of Biotechnology, Punjabi University, Patiala 147002, Punjab, India. rssingh11@lycos.com.
Mushroom lectins show anti-proliferative effects, offering potential as novel antitumor drugs. Further research into their mechanisms can expand their use in cancer therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Lectins are proteins/glycoproteins of non-immune origin that bind to carbohydrates.
- They can alter cell membrane physiology and trigger biochemical changes.
- Lectins have potential applications in cancer diagnostics and therapy by inducing apoptosis.
Purpose of the Study:
- To review the anti-proliferative activity of mushroom lectins.
- To discuss the mechanisms underlying their anti-proliferative effects.
- To explore the potential of mushroom lectins as novel antitumor drugs.
Main Methods:
- Review of in-vitro and in-vivo studies on mushroom lectins.
- Analysis of the mechanisms of anti-proliferative activity.
- Discussion of potential therapeutic applications.
Main Results:
- Mushroom lectins exhibit significant anti-proliferative activity.
- Various mechanisms contribute to their antitumor effects.
- Unique specificities of mushroom lectins offer biotechnological potential.
Conclusions:
- Mushroom lectins are promising candidates for cancer therapeutics.
- Understanding their action mechanisms is crucial for drug development.
- Further investigation may lead to novel antitumor drugs.
More Related Videos
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules
Cancer Prevention
Some...
Selectins
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy